Similarly, lncRNA H19 could regulate HER2 expression through sequestering let-7c in gastric cancer cells [30], indicating the potiential of ncRNAs may modulate sensitivity to targeted therapy. The gene discussed is ERBB2; the disease is gastric cancer.